News 2010

Thuja Capital adds Dr. Staf Van Reet to its scientific advisory board

Date: 15/12/2010

Utrecht, The Netherlands – Thuja Capital today announced that Dr. Staf Van Reet has joined its Scientific Advisory Board. (more…)

Onno van de Stolpe joins Supervisory Board of DCPrime

Date: 15/12/2010

Amsterdam, The Netherlands – DCPrime is proud to announce that Onno van de Stolpe, CEO of Galapagos, will join (more…)

Teijin Aramid and Avantium enter partnership

Date: 06/10/2010

Amsterdam, The Netherlands – Teijin Aramid and Avantium entered a partnership to explore green high-performance polymers. See the website of Avantium for more information.

Galapagos starts Phase II clinical trial in rheumatoid arthritis patients

Date: 28/09/2010

Mechelen, Belgium – Galapagos starts a Phase II clinical study in RA patients. See website for more info.

Thuja Capital Healthcare Seed Fund invests in DCPrime B.V.

Date: 20/09/2010

Utrecht, The Netherlands – Thuja Capital announced today that it has invested in cancer vaccine company DCPrime B.V. (more…)

Evotec AG to acquire majority holding in Develogen AG

Date: 14/07/2010

Goettingen, Germany – Evotec AG to acquire majority holding in Develogen AG. See website for more information.

Cosmo Pharmaceuticals announces preliminary end result of its tender offer for BioXell

Date: 01/03/2010

Milan, Italy – Cosmo Pharmaceuticals announces preliminary end result of its tender offer for BioXell. See website for more info.

Thuja Capital Healthcare Seed Fund invests in Fabpulous B.V.

Date: 11/01/2010

Utrecht, The Netherlands – Thuja Capital announced today that it invested in Fabpulous B.V., (more…)